Sign in
Not yet recruitingEarly phase 1

Effect of Remimazolam Versus Dexmedetomidine on the Incidence of Delirium After Elective Cardiac Surgery with Cardiopulmonary Bypass: a Prospective Randomized Controlled Trial

Key facts

Who runs it
Assiut University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
Phase
Early phase 1
People taking part
111 people, planned
Started
10 Jan 2025
Expected to end
1 Nov 2027
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Propofol Group 1
  • Remimazolam Intervention
  • Dexmedetomidine Intervention
Record updated
1 January 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age ≥18 years
  • Scheduled for cardiac surgery (CABG and/or valve replacement)
  • Elective surgery

Who cannot take part

  • Patients with known allergies to Remimazolam or Dexmedetomidine
  • History of psychiatric or neurological conditions (schizophrenia, epilepsy, severe dementia, etc.)
  • Refusal to participate
  • Preoperative inability to communicate (severe visual/auditory dysfunction, language barriers)
  • Severe hepatic or renal dysfunction
  • Cardiopulmonary bypass time not ≥ 120 minutes
  • aortic clamping time not ≥ 90 minutes
  • Emergency surgeries
  • On preoperative mechanical ventilation and long sedation time
  • reoperated patients

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The study aims to improve the post-open heart surgery lifestyle and overall experience, as well as assess the incidence of delirium using Remimazolam and Dexmedetomidine.

The 3 groups in the trial

  • Group 1 : propofol groupPlacebo, for comparison

    Postoperative Use

    Treatment: Propofol Group 1

  • Group 2: Remimazolam InterventionTreatment being tested

    Postoperative Use

    Treatment: Remimazolam Intervention

  • Group 3: Dexmedetomidine InterventionTreatment being tested

    Postoperative Use

    Treatment: Dexmedetomidine Intervention

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
1 January 2025